Arti Hurria

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Developing a cancer-specific geriatric assessment: a feasibility study
    Arti Hurria
    Department of Medicine, Psychiatry and Behavioral Sciences, and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 104:1998-2005. 2005
  2. doi Cognitive effects of hormonal therapy in older adults
    Nicholas Mitsiades
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Semin Oncol 35:569-81. 2008
  3. doi Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible
    Chau Dang
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Clin Breast Cancer 8:418-24. 2008
  4. pmc Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer
    Marjorie Zauderer
    NewYork Presbyterian Hospital, New York, USA
    Breast Cancer Res Treat 117:205-10. 2009
  5. pmc Mentoring junior faculty in geriatric oncology: report from the Cancer and Aging Research Group
    Arti Hurria
    City of Hope, Duarte, CA, USA
    J Clin Oncol 26:3125-7. 2008
  6. ncbi Pharmacokinetics and toxicity of weekly docetaxel in older patients
    Arti Hurria
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York 10021, USA
    Clin Cancer Res 12:6100-5. 2006
  7. ncbi A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy
    Arti Hurria
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Am Geriatr Soc 54:1119-24. 2006
  8. ncbi Factors influencing treatment patterns of breast cancer patients age 75 and older
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Crit Rev Oncol Hematol 46:121-6. 2003
  9. ncbi Geriatric assessment for oncologists: rationale and future directions
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Crit Rev Oncol Hematol 59:211-7. 2006
  10. ncbi Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Am Geriatr Soc 54:925-31. 2006

Detail Information

Publications47

  1. ncbi Developing a cancer-specific geriatric assessment: a feasibility study
    Arti Hurria
    Department of Medicine, Psychiatry and Behavioral Sciences, and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 104:1998-2005. 2005
    ....
  2. doi Cognitive effects of hormonal therapy in older adults
    Nicholas Mitsiades
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Semin Oncol 35:569-81. 2008
    ....
  3. doi Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible
    Chau Dang
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Clin Breast Cancer 8:418-24. 2008
    ..Dose-dense EC (without the 5-FU) is not associated with pneumonitis, and dose-dense paclitaxel (alone) is feasible. Primary objective was feasibility...
  4. pmc Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer
    Marjorie Zauderer
    NewYork Presbyterian Hospital, New York, USA
    Breast Cancer Res Treat 117:205-10. 2009
    ..The objective of this study was to examine the feasibility and toxicity of adjuvant dose-dense chemotherapy in older women with breast cancer...
  5. pmc Mentoring junior faculty in geriatric oncology: report from the Cancer and Aging Research Group
    Arti Hurria
    City of Hope, Duarte, CA, USA
    J Clin Oncol 26:3125-7. 2008
  6. ncbi Pharmacokinetics and toxicity of weekly docetaxel in older patients
    Arti Hurria
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York 10021, USA
    Clin Cancer Res 12:6100-5. 2006
    ....
  7. ncbi A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy
    Arti Hurria
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Am Geriatr Soc 54:1119-24. 2006
    ..To examine the toxicity experienced by a cohort of older women receiving adjuvant chemotherapy for breast cancer and the longitudinal effect on their functional status and quality of life (QOL)...
  8. ncbi Factors influencing treatment patterns of breast cancer patients age 75 and older
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Crit Rev Oncol Hematol 46:121-6. 2003
    ..To retrospectively determine the factors influencing treatment decisions in older breast cancer patients at a single center...
  9. ncbi Geriatric assessment for oncologists: rationale and future directions
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Crit Rev Oncol Hematol 59:211-7. 2006
    ..Our eventual goal is to determine if this geriatric assessment measure can identify factors independent of age that predict cancer treatment morbidity and mortality and result in rationale interventions to optimize oncologic care...
  10. ncbi Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Am Geriatr Soc 54:925-31. 2006
    ..To report on the longitudinal cognitive functioning of older women receiving adjuvant chemotherapy for breast cancer...
  11. ncbi Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Breast Cancer Res Treat 98:343-8. 2006
    ..This longitudinal prospective study describes the older breast cancer patient's perception of the cognitive impact of adjuvant chemotherapy...
  12. ncbi Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Drugs Aging 22:785-91. 2005
    ..We sought to determine the association between calculated creatinine clearance (CL(CR)) and grade 3 or 4 toxicities during adjuvant chemotherapy in women > or =65 years of age with breast cancer...
  13. ncbi Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, NY 10021, New York, USA
    Breast Cancer Res Treat 92:151-6. 2005
    ..To retrospectively determine the relationship of age to toxicity from adjuvant chemotherapy for breast cancer...
  14. ncbi Screening chest imaging studies are not effective in the follow-up of breast cancer patients
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Oncol Manag 12:13-5. 2003
    ..To determine the utility of chest imaging after adjuvant therapy for breast cancer in detection of recurrent disease...
  15. pmc CA125 level association with chemotherapy toxicity and functional status in older women with ovarian cancer
    Elizabeth Won
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Gynecol Cancer 23:1022-8. 2013
    ..CA125 is a sensitive biomarker for tumor burden. The study evaluates the association between CA125, geriatric assessment (GA), and treatment toxicity...
  16. ncbi Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapy
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Drugs Aging 22:709-15. 2005
    ..To determine the association between changes in complete blood counts and grade 3 or 4 toxicities from cycle 1 to cycle 2 during adjuvant chemotherapy in women > or =65 years of age with breast cancer...
  17. pmc Anemia and Functional Disability in Older Adults With Cancer
    Cynthia Owusu
    From Case Western Reserve University, Cleveland, Ohio Duke University School of Medicine, Durham, North Carolina City of Hope Comprehensive Cancer Center, Duarte, California Memorial Sloan Kettering Cancer Center, New York, New York University of Rochester, Rochester, New York Wake Forest School of Medicine, Winston Salem, North Carolina Cancer Outcomes Public Policy and Effectiveness COPPER Center, Yale University School of Medicine, New Haven, Connecticut and Upstate Medical University and VA Medical Center, Syracuse, New York
    J Natl Compr Canc Netw 13:1233-9. 2015
    ..Therefore, we examined the association between anemia and functional disability in patients with cancer aged 65 years or older...
  18. ncbi Management of lung cancer in older adults
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY, USA
    CA Cancer J Clin 53:325-41. 2003
    ..This article reviews the available data regarding surgery, radiation, and systemic treatment for older patients with lung cancer and considers the role of geriatric assessment in the evaluation of older patients...
  19. ncbi Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Crit Rev Oncol Hematol 61:255-60. 2007
    ..Previous studies demonstrate differing treatment patterns between older and younger patients with breast cancer. To explore the reasons for these disparities we conducted a survey of 28 oncologists specializing in breast cancer...
  20. ncbi Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer
    Chau T Dang
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Clin Cancer Res 10:5754-61. 2004
    ..The primary objective was to determine the feasibility of the regimen; the secondary objective was to estimate the disease-free and overall survival...
  21. pmc The relationship between age, anxiety, and depression in older adults with cancer
    Talia R Weiss Wiesel
    Payne Whitney Manhattan, NewYork Presbyterian Hospital, Weill Cornell Medical Center, New York, NY, USA
    Psychooncology 24:712-7. 2015
    ..The purpose of this study was to examine the association among age, anxiety, and depression in a cohort of older adults receiving chemotherapy...
  22. pmc Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer
    Arti Hurria
    Arti Hurria, Tao Feng, David Smith, Can Lan Sun, Vani Katheria, Caroline Doan, Laura Zavala, Abrahm Levi, and Chie Akiba, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA Supriya Mohile, University of Rochester Medical Center, Rochester Ajeet Gajra, Upstate Medical University and Syracuse VA Medical Center, Syracuse William P Tew, Memorial Sloan Kettering Cancer Center, New York, NY Heidi Klepin, Wake Forest University School of Medicine, Winston Salem Hyman Muss, University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill Harvey Jay Cohen, Duke University, Durham, NC Andrew Chapman, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA and Nienke De Glas, Leiden University Medical Centre, Leiden, The Netherlands
    J Clin Oncol 34:2366-71. 2016
    ..A predictive model for chemotherapy toxicity was developed (N = 500) that consisted of geriatric assessment questions and other clinical variables. This study aims to externally validate this model in an independent cohort (N = 250)...
  23. pmc Toxicity of bevacizumab in combination with chemotherapy in older patients
    Supriya G Mohile
    University of Rochester Medical Center, Wilmot Cancer Center, Rochester, New York, USA
    Oncologist 18:408-14. 2013
    ..Little is known about factors associated with receipt of bevacizumab, or whether bevacizamab is associated with increased toxicity when added to chemotherapy...
  24. doi Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer
    Jersey Chen
    Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA
    J Am Coll Cardiol 60:2504-12. 2012
    ..The purpose of this study was to estimate heart failure (HF) and cardiomyopathy (CM) rates after adjuvant trastuzumab therapy and chemotherapy in a population of older women with early-stage breast cancer...
  25. pmc Improving the quality of survivorship for older adults with cancer
    Supriya G Mohile
    Department of Medicine, University of Rochester, Rochester, New York
    Cancer 122:2459-568. 2016
    ..Cancer 2016;122:2459-68. © 2016 American Cancer Society. ..
  26. pmc Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)
    Maura N Dickler
    Maura N Dickler, Mary Ellen Moynahan, Diana E Lake, and Clifford A Hudis, Memorial Sloan Kettering Cancer Center, New York, NY William T Barry, Dana Farber Cancer Institute Eric P Winer, Dana Farber Partners Cancer Care, Boston, MA Constance T Cirrincione, Duke University, Durham, NC Matthew J Ellis, Baylor College of Medicine Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX Federico Innocenti and Lisa A Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC Arti Hurria, City of Hope, Duarte Hope S Rugo, University of California at San Francisco, San Francisco, CA Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL and Bryan P Schneider, Indiana University School of Medicine, Indianapolis, IN
    J Clin Oncol 34:2602-9. 2016
    ..To investigate whether anti-vascular endothelial growth factor therapy with bevacizumab prolongs progression-free survival (PFS) when added to first-line letrozole as treatment of hormone receptor-positive metastatic breast cancer (MBC)...
  27. pmc Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907
    Stuart M Lichtman
    Stuart M Lichtman and Maria Theodoulou, Memorial Sloan Kettering Cancer Center, New York, NY Constance T Cirrincione, Duke University Harvey Jay Cohen, Duke University Medical Center, Durham Gustave Magrinat, Cone Health Cancer Center, Greensboro Hyman B Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC Arti Hurria, City of Hope, Duarte, CA Aminah Jatoi, Mayo Clinic, Rochester, MN Antonio C Wolff, The Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD Julie Gralow, Seattle Cancer Care Alliance, Seattle, WA and Daniel E Morganstern, Dana Farber Cancer Institute, Boston, MA
    J Clin Oncol 34:699-705. 2016
    ..The purpose of the current analysis was to assess the relationship between pretreatment renal function and five end points: toxicity, dose modification, therapy completion, relapse-free survival, and overall survival...
  28. doi Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement
    Arti Hurria
    Arti Hurria, City of Hope, Duarte Louis Fehrenbacher, Kaiser Permanente Northern California, Vallejo, CA Enrique Soto Perez de Celis, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico Laura A Levit and Suanna S Bruinooge, American Society of Clinical Oncology, Alexandria, VA William Dale, University of Chicago Medical Center, Chicago, IL Supriya G Mohile and Allison Magnuson, University of Rochester Medical Center, Rochester Stuart M Lichtman, William P Tew, and Michael A Postow, Memorial Sloan Kettering Cancer Center, New York, NY Hyman B Muss, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill and Harvey J Cohen, Duke University Medical Center, Durham, NC
    J Clin Oncol 33:3826-33. 2015
    ....
  29. ncbi Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort
    Elena B Elkin
    Health Outcomes Research Group and Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 24:2757-64. 2006
    ..Our goal was to assess the relationship between adjuvant chemotherapy use and survival in a large, population-based cohort of older women with hormone receptor (HR) -negative breast cancer...
  30. pmc Use of complementary medications among older adults with cancer
    Ronald J Maggiore
    Department of Medicine, Sections of Geriatrics Palliative Medicine and Hematology Oncology, University of Chicago Medical Center, Chicago, Illinois, USA
    Cancer 118:4815-23. 2012
    ..The objective of this study was to evaluate the prevalence of complementary medication use and to identify the factors associated with its use among older adults with cancer...
  31. ncbi Follow-up care of breast cancer survivors
    Arti Hurria
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue 815, New York, NY 10021, USA
    Crit Rev Oncol Hematol 48:89-99. 2003
    ..In this article, we will discuss the principles of follow-up care of the breast cancer survivor...
  32. pmc Assessing depression in a geriatric cancer population
    Rebecca M Saracino
    Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Psychooncology . 2016
    ..To examine the ability of three popular self-report measures of depression to assess depression in a geriatric cancer setting...
  33. ncbi Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527
    Rachel A Freedman
    Rachel A Freedman, Eric P Winer, and Ann H Partridge, Dana Farber Cancer Institute, Boston, MA Jared C Foster, Drew K Seisler, Jacqueline M Lafky, and Aminah Jatoi, Mayo Clinic Jared C Foster and Drew K Seisler, Mayo Cancer Center, Rochester, MN Hyman B Muss and Lisa A Carey, University of North Carolina, Chapel Hill, NC Harvey J Cohen, Constance Cirrincione, and Gretchen Kimmick, Duke University, Durham, NC Jeanne Mandelblatt, Georgetown University, Washington, DC Clifford A Hudis, Memorial Sloan Kettering Cancer Center, New York, NY Alvaro Moreno Aspitia, Mayo Clinic, Jacksonville, FL and Arti Hurria, City of Hope, Duarte, CA
    J Clin Oncol . 2016
    ..Novel strategies to increase accrual of older patients are critical to meaningfully change the evidence base for this growing patient population...
  34. ncbi Functional assessment of the older patient with cancer
    Cathy C Schubert
    Department of Internal Medicine and Geriatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA
    Oncology (Williston Park) 22:916-22; discussion 925, 928. 2008
    ..Including these tools in daily oncology practice could help physicians to better assess and treat vulnerable older adults...
  35. ncbi NCCN Task Force Report: breast cancer in the older woman
    Robert W Carlson
    J Natl Compr Canc Netw 6:S1-25; quiz S26-7. 2008
    ....
  36. ncbi Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology
    Hans Wildiers
    Department of General Medical Oncology, University Hospital Gasthuisberg, Leuven, Belgium
    Lancet Oncol 8:1101-15. 2007
    ..The available evidence was reviewed and synthesised to provide consensus recommendations regarding the care of breast cancer in older adults...
  37. ncbi Incorporation of geriatric principles in oncology clinical trials
    Arti Hurria
    J Clin Oncol 25:5350-1. 2007
  38. ncbi Use of postmastectomy radiotherapy in older women
    Benjamin D Smith
    Radiation Oncology Flight, Wilford Hall Medical Center, Lackland Air Force Base, TX, USA
    Int J Radiat Oncol Biol Phys 71:98-106. 2008
    ..Using the Surveillance, Epidemiology, and End Results-Medicare cohort, we sought to characterize the adoption of PMRT from 1992 to 2002 and identify risk factors for PMRT omission among high-risk older patients...
  39. ncbi Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice
    Arti Hurria
    Division of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California 91010, USA
    J Am Geriatr Soc 55:1604-8. 2007
    ..To integrate the principles of geriatric assessment into the care of older patients with cancer in order to identify vulnerable older adults and develop interventions to optimize cancer treatment...
  40. ncbi Comprehensive geriatric assessment for older patients with cancer
    Martine Extermann
    H Lee Moffitt Cancer Center, University of South Florida, Tampa, FL 33612, USA
    J Clin Oncol 25:1824-31. 2007
    ..This article discusses recent advances on the use of a CGA in older patients with cancer...
  41. ncbi Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer?
    Arti Hurria
    City of Hope, Duarte, CA 91010, USA
    Breast Cancer Res Treat 103:259-68. 2007
    ..Since aging is the number one risk factor for breast cancer, future studies of the neuropsychological impact of chemotherapy should include older patients...
  42. ncbi Pharmacokinetics of chemotherapy in the older patient
    Arti Hurria
    Cancer and Aging Research Program, City of Hope National Medical Center, Duarte, CA 91010, USA
    Cancer Control 14:32-43. 2007
    ..Age-related changes in physiology can affect chemotherapy pharmacokinetics and pharmacodynamics in older patients...
  43. ncbi We need a geriatric assessment for oncologists
    Arti Hurria
    Division of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA
    Nat Clin Pract Oncol 3:642-3. 2006
  44. ncbi Postmastectomy radiation and survival in older women with breast cancer
    Benjamin D Smith
    Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA
    J Clin Oncol 24:4901-7. 2006
    ..As recent evidence suggests that certain adjuvant treatments appropriate for younger women may only be marginally beneficial for older women, we sought to determine whether PMRT improves survival for older women with breast cancer...
  45. ncbi Do age and ethnicity predict breast cancer treatment received? A cross-sectional urban population based study. Breast cancer treatment: age and ethnicity
    Arash Naeim
    Division of Hematology Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095 1687, USA
    Crit Rev Oncol Hematol 59:234-42. 2006
    ..To evaluate the treatment patterns of women aged 55 years or older with newly diagnosed breast cancer and to examine the association between age and ethnicity/race on treatment selection...
  46. ncbi Renaming "chemobrain"
    Arti Hurria
    City of Hope, Duarte, CA 91010, USA
    Cancer Invest 25:373-7. 2007
    ..We propose that the phenomenon commonly referred to as "chemobrain" would be more accurately labeled "cancer- or cancer-therapy-associated cognitive change."..
  47. ncbi Clinical trials in older adults with cancer: past and future
    Arti Hurria
    Cancer and Aging Research Program, City of Hope Cancer Center, Duarte, California 91010, USA
    Oncology (Williston Park) 21:351-8; discussion 363-4, 367. 2007
    ..This article examines the demographics of cancer and aging, the barriers to enrollment of older adults on clinical trials, and approaches for future trials to address the needs of the older patient...